Clinical Trials Browser

Phase 2 × Neoplasms × monalizumab × Clear all

NCT06152523 2026-04-06

MONAMI

Phase 2 Withdrawn

Neoplasms

NCT03822351 2024-10-08

COAST

Phase 2 Completed

189 enrolled 24 charts

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT04333914 2022-09-30

IMMUNONCOVID

Phase 2 Completed

COVID-19, Infections, Neoplasms

NCT03794544 2022-02-24

Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer

Phase 2 Completed

84 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung, Neoplasms